Your institution may have access to this item. Find your institution then sign in to continue.
Title
FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer.
Authors
Bergh, Jonas; Jönsson, Per-Ebbe; Lidbrink, Elisabet Kerstin; Trudeau, Maureen; Eiermann, Wolfgang; Brattström, Daniel; Lindemann, Justin P. O.; Wiklund, Fredrik; Henriksson, Roger
Publication
Journal of Clinical Oncology, 2012, Vol 30, Issue 16, p1919